NCOA2 and mesenchymal chondrosarcoma: In support of this idea, Sox9 expression was maintained upon HEY1::NCOA2 introduction throughout the carcinogenic process of mesenchymal chondrosarcoma, as Sox9 is expressed at high level in eSZ cells.